Jacobs Levy Equity Management, Inc Iveric Bio, Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.65 - $7.66 $588,311 - $797,605	-104,126 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.01 - $6.29 $132,153 - $207,293	-32,956 Reduced 24.04%	104,126 $587,000
Q1 2020 May 15, 2020	SELL	$2.83 - $8.44 $3,398 - $10,136	-1,201 Reduced 0.87%	137,082 $472,000
Q4 2019 Feb 14, 2020	SELL	$0.93 - $8.58 $23,435 - $216,207	-25,199 Reduced 15.41%	138,283 $1.19 Million
Q3 2019 Nov 14, 2019	SELL	$1.09 - $1.29 $92,409 - $109,364	-84,779 Reduced 34.15%	163,482 $183,000
Q2 2019 Aug 13, 2019	BUY	$1.21 - $1.48 $300,395 - $367,426	248,261 New	248,261 $323,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.